JP2010510994A5 - - Google Patents

Download PDF

Info

Publication number
JP2010510994A5
JP2010510994A5 JP2009538564A JP2009538564A JP2010510994A5 JP 2010510994 A5 JP2010510994 A5 JP 2010510994A5 JP 2009538564 A JP2009538564 A JP 2009538564A JP 2009538564 A JP2009538564 A JP 2009538564A JP 2010510994 A5 JP2010510994 A5 JP 2010510994A5
Authority
JP
Japan
Prior art keywords
peptide
seq
immunogenic composition
composition
based immunogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009538564A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010510994A (ja
JP5177451B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2007/002164 external-priority patent/WO2008064488A1/en
Publication of JP2010510994A publication Critical patent/JP2010510994A/ja
Publication of JP2010510994A5 publication Critical patent/JP2010510994A5/ja
Application granted granted Critical
Publication of JP5177451B2 publication Critical patent/JP5177451B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009538564A 2006-11-30 2007-11-30 インフルエンザワクチン製剤 Expired - Fee Related JP5177451B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86800806P 2006-11-30 2006-11-30
US60/868,008 2006-11-30
PCT/CA2007/002164 WO2008064488A1 (en) 2006-11-30 2007-11-30 Influenza vaccine formulation

Publications (3)

Publication Number Publication Date
JP2010510994A JP2010510994A (ja) 2010-04-08
JP2010510994A5 true JP2010510994A5 (enExample) 2011-01-27
JP5177451B2 JP5177451B2 (ja) 2013-04-03

Family

ID=39467397

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009538564A Expired - Fee Related JP5177451B2 (ja) 2006-11-30 2007-11-30 インフルエンザワクチン製剤

Country Status (6)

Country Link
US (2) US7807173B2 (enExample)
EP (1) EP2097103B1 (enExample)
JP (1) JP5177451B2 (enExample)
CN (1) CN101622009B (enExample)
CA (1) CA2670965C (enExample)
WO (1) WO2008064488A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5177451B2 (ja) * 2006-11-30 2013-04-03 ヴァリエーション バイオテクノロジーズ インコーポレイテッド インフルエンザワクチン製剤
WO2009155489A2 (en) 2008-06-19 2009-12-23 Variation Biotechnologies, Inc. Compositions and methods for treating influenza
WO2011138032A2 (en) * 2010-05-05 2011-11-10 Artemev, Timur Universal influenza vaccines and methods for their generation
WO2013072768A2 (en) 2011-11-18 2013-05-23 Variation Biotechnologies, Inc. Synthetic derivatives of mpl and uses thereof
JP2018528191A (ja) * 2015-08-19 2018-09-27 ラトガーズ, ザ ステイト ユニバーシティ オブ ニュー ジャージー 抗体を生成する新規な方法
JP7187448B2 (ja) 2016-09-20 2022-12-12 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー 新しいプロモーター

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7118874B2 (en) * 1998-10-09 2006-10-10 Variation Biotechnologies Inc. Immunogenic formulation and process for preparation thereof
US6896881B1 (en) * 1999-09-24 2005-05-24 Mayo Foundation For Medical Education And Research Therapeutic methods and compositions using viruses of the recombinant paramyxoviridae family
CN1163271C (zh) * 2000-08-10 2004-08-25 清华大学 一种合成肽流感疫苗的制备方法
EA008143B1 (ru) * 2002-02-08 2007-04-27 Вариейшн Байотекнолоджиз, Инк. Иммуногенные композиции из вариабельных пептидных эпитопов и способ их получения
EP1603590A4 (en) * 2003-03-07 2008-08-27 Merck & Co Inc INFLUENZA VIRUS VACCINE
MX2007015105A (es) * 2005-06-01 2008-03-18 Variation Biotechnologies Inc Formulacion de vacuna de influenza a base de peptido.
US20090169576A1 (en) * 2005-10-26 2009-07-02 Roberto Crea Influenza combinatorial antigen vaccine
JP2009514536A (ja) * 2005-11-07 2009-04-09 シドニー キンメル キャンサー センター Cd40リガンド融合蛋白質ワクチン
WO2008112017A2 (en) * 2006-10-10 2008-09-18 The Government Of The United States Of America, As Represented By The Secretary, Department Of Healtand Human Services Avian influenza vaccine
JP5177451B2 (ja) * 2006-11-30 2013-04-03 ヴァリエーション バイオテクノロジーズ インコーポレイテッド インフルエンザワクチン製剤

Similar Documents

Publication Publication Date Title
JP2006006329A5 (enExample)
NO2023048I1 (en) A composition comprising: cedazuridine or a pharmaceutically acceptable salt thereof, and decitabine
JP2009524695A5 (enExample)
JP2006213929A5 (enExample)
JP2010065037A5 (enExample)
IL247741B (en) Pharmaceutical preparations containing iron oxo-hydroxide, methods for their preparation and their uses
JP2010501534A5 (enExample)
JP2011526809A5 (enExample)
JP2007169302A5 (enExample)
JP2010088434A5 (enExample)
JP2010510994A5 (enExample)
JP2009520682A5 (enExample)
JP2008533990A5 (enExample)
JP2008519810A5 (enExample)
JP2009509934A5 (enExample)
JP2007508806A5 (enExample)
GB0704352D0 (en) "Peptide, compositions and uses thereof"
JP2005531640A5 (enExample)
张华全 胶东山后金矿区构造控矿规律浅析
杨小斌 et al. 青海省果洛龙洼金矿床矿石及矿物特征研究
李田玉 某含金废料熔炼渣型试验研究
JP2008545704A5 (enExample)
叶舟 The Wholeness of Life
甘文胜 Do I Know You?
张忠宝 福建某金银矿山氰化厂设计中的问题探讨